you are here:

Aurobindo Pharma Ltd.

BSE: 524804 | NSE: AUROPHARMA |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE406A01037 | SECTOR: Pharmaceuticals

BSE Live

Mar 04, 16:00
874.50 -6.30 (-0.72%)
Volume
AVERAGE VOLUME
5-Day
189,936
10-Day
214,500
30-Day
191,103
117,699
  • Prev. Close

    880.80

  • Open Price

    871.50

  • Bid Price (Qty.)

    874.50 (1)

  • Offer Price (Qty.)

    874.50 (18)

NSE Live

Mar 04, 15:59
874.90 -5.60 (-0.64%)
Volume
AVERAGE VOLUME
5-Day
2,305,589
10-Day
2,473,004
30-Day
3,364,346
1,523,420
  • Prev. Close

    880.50

  • Open Price

    874.90

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    874.90 (5)

Financials

2020 2019 2018 2017 2016
Quarterly Results of Aurobindo Pharma (in Rs. Cr.) Dec '20 Sep '20 Jun '20 Mar '20 Dec '19  
Net Sales/Income from operations 3,701.14 4,425.43 3,337.25 3,534.28 3,258.10  
Other Operating Income 9.72 98.91 82.45 86.04 87.57  
Total Income From Operations 3,710.86 4,524.34 3,419.70 3,620.32 3,345.67  
EXPENDITURE  
Consumption of Raw Materials 1,750.70 1,833.20 1,791.43 1,792.76 1,753.23  
Purchase of Traded Goods 3.48 2.45 5.14 0.68 1.11  
Increase/Decrease in Stocks -97.45 361.51 -380.86 -126.92 -64.90  
Power & Fuel -- -- -- -- --  
Employees Cost 431.08 426.62 424.69 424.94 384.91  
depreciat 120.63 120.14 119.79 118.85 118.55  
Excise Duty -- -- -- -- --  
Admin. And Selling Expenses -- -- -- -- --  
R & D Expenses -- -- -- -- --  
Provisions And Contingencies -- -- -- -- --  
Exp. Capitalised -- -- -- -- --  
Other Expenses 649.30 693.42 614.47 680.27 620.14  
P/L Before Other Inc. , Int., Excpt. Items & Tax 853.12 1,087.00 845.04 729.74 532.63  
Other Income 164.97 48.62 125.58 160.61 37.98  
P/L Before Int., Excpt. Items & Tax 1,018.09 1,135.62 970.62 890.35 570.61  
Interest 5.84 6.42 10.43 17.46 21.31  
P/L Before Exceptional Items & Tax 1,012.25 1,129.20 960.19 872.89 549.30  
Exceptional Items -- -- -- -- --  
P/L Before Tax 1,012.25 1,129.20 960.19 872.89 549.30  
Tax 271.74 327.66 245.51 147.85 130.23  
P/L After Tax from Ordinary Activities 740.51 801.54 714.68 725.04 419.07  
Prior Year Adjustments -- -- -- -- --  
Extra Ordinary Items -- -- -- -- --  
Net Profit/(Loss) For the Period 740.51 801.54 714.68 725.04 419.07  
Equity Share Capital 58.59 58.59 58.59 58.59 58.59  
Reserves Excluding Revaluation Reserves -- -- -- -- --  
Equity Dividend Rate (%) -- -- -- -- --  
EPS Before Extra Ordinary  
Basic EPS 12.64 13.68 12.20 12.37 7.15  
Diluted EPS 12.64 13.68 12.20 12.37 7.15  
EPS After Extra Ordinary  
Basic EPS. 12.64 13.68 12.20 12.37 7.15  
Diluted EPS. 12.64 13.68 12.20 12.37 7.15  
Public Share Holding  
No Of Shares (Crores) -- -- -- -- --  
Share Holding (%) -- -- -- -- --  
Promoters and Promoter Group Shareholding  
a) Pledged/Encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
b) Non-encumbered  
- Number of shares (Crores). -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group). -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company). -- -- -- -- --  
Source : Dion Global Solutions Limited